USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.21 | $-0.80 | $-0.21 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $60.63M | $59.63M | $47.19M |
Health Catalyst, Inc's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 12 | $-0.20 | $-0.35 | $-0.12 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 13 | $-0.49 | $-0.88 | $-0.40 |
| Dec 2022 | 13 | $-0.36 | $-1.25 | $-0.06 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.19 | $-0.19 | $-0.14 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.48 | $-0.48 | $-0.58 |
| Dec 2022 | 0 / 0 | $-0.30 | $-0.32 | $-0.31 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 12 | $62.49M | $59.60M | $64.90M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 13 | $239.02M | $236.98M | $241.90M |
| Dec 2022 | 13 | $290.47M | $285.17M | $297.00M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.21 | - | - |
| Aug 5, 2021 | Jun 2021 | $-0.14 | $-0.80 | -483.55% |
| May 6, 2021 | Mar 2021 | $-0.14 | $-0.06 | 58.51% |
| Feb 25, 2021 | Dec 2020 | $-0.20 | $-0.16 | 20.20% |
| Nov 10, 2020 | Sep 2020 | $-0.27 | $-0.21 | 22.11% |
| Aug 11, 2020 | Jun 2020 | $-0.22 | $-0.15 | 32.55% |
| May 12, 2020 | Mar 2020 | $-0.26 | $-0.16 | 37.60% |
| Feb 27, 2020 | Dec 2019 | $-0.28 | $-0.21 | 25.95% |
| Nov 12, 2019 | Sep 2019 | $-0.37 | $-0.27 | 27.16% |
| Aug 22, 2019 | Jun 2019 | $-0.32 | $-0.21 | 35.09% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 25, 2021 | Dec 2020 | $-0.72 | $-0.68 | - |
| Feb 27, 2020 | Dec 2019 | $-1.08 | $-0.69 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $60.63M | - | - |
| Aug 5, 2021 | Jun 2021 | $57.08M | $59.63M | 1.04% |
| May 6, 2021 | Mar 2021 | $54.42M | $55.85M | 1.03% |
| Feb 25, 2021 | Dec 2020 | $53.28M | $53.28M | 1.00% |
| Nov 10, 2020 | Sep 2020 | $44.59M | $47.19M | 1.06% |
| Aug 11, 2020 | Jun 2020 | $42.14M | $43.26M | 1.03% |
| May 12, 2020 | Mar 2020 | $43.47M | $45.12M | 1.04% |
| Feb 27, 2020 | Dec 2019 | $41.89M | $43.50M | 1.04% |
| Nov 12, 2019 | Sep 2019 | $37.71M | $39.42M | 1.05% |
| Aug 22, 2019 | Jun 2019 | $36.80M | $36.80M | 1.00% |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 25, 2021 | Dec 2020 | $188.84M | $188.84M | 0.00% |
| Feb 27, 2020 | Dec 2019 | $153.43M | $154.94M | 0.98% |
HCAT's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 12 analysts, the average EPS estimation for Health Catalyst, Inc's next quarterly earnings is $-0.21, with a low EPS estimation of $-0.36, and a high estimation of $-0.14.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.20, the last 2 month trend is $-0.20, and the 3 month trend is $-0.17.
Based on 10 analysts, the average revenue estimation is $60.63M, with a low revenue estimation of $58.80M, and a high estimation of $62.24M.
Health Catalyst, Inc's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.
HCAT's earnings per share (EPS) was $-0.80, missing the consensus analysts forecast of $-0.14 by -483.55%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 1230.50%, and lower than the same period a year before (Jun 2020) by 432.20%.
Revenues were $59.63M, better than the forecast of $57.08M by 4.46%, up by 6.77% from the previous quarter , and up by 37.84% from the same period last year.
The company reported a net income of $-35.83M.Free cash flow for the quarter was $-8.42M , compared to $-10.39M last quarter and $-1.74M a year before.
HCAT ended the quarter with $199.64M in total debt, an increase of 1.14% compared to the previous quarter, and a decrease of -51.59% compared to the same quarter a year before.
Health Catalyst, Inc's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.
HCAT's earnings per share (EPS) was $-0.68, beating the consensus analysts forecast of $-0.72 by -5.56% , and higher than the previous year's EPS (Dec 2019) by -1.45%.
Revenues were $188.84M, better than the forecast of $188.84M by 0.00%, and up by 21.88% from previous year's revenue.
The company reported a net income of $-115.02M.
Health Catalyst, Inc reported a free cash flow of $-33.92M for its fiscal year, compared to $-36.52M a year ago.
The company ended the fiscal year with $192.66M in total debt, a decrease of -25.45% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
